Total expenditure on Japanese R&D for fiscal year 2014 increased 4.6%, totaling ¥18.97 trillion ($15.76 billion). As a percentage of GDP, R&D expenditure rose 0.12% to represent 4%. R&D in business enterprises accounted for 72% of R&D expenditures, a 7.0% increase. By main industries of business enterprises, “Transportation Equipment” accounted for 21%, or ¥2.84 trillion […]
Spain has announced the creation of the State Research Agency, which will fund scientific research. It replaces the State Secretariat for Research Development and Innovation. It will not receive new funding but rather reallocated funding. The new Agency will have around 300 employees and will be formed through a spin-off of resources from the Secretariat. […]
Chinese R&D spending grew 12.4% in 2014 to CNY 1,331.2 billion ($216 billion) or 2.09% of GDP. Five percent was for “fundamental research programs.” In 2013, R&D spending increased 15.0%. The number of authorized patents fell 0.8% in 2014 to 130,000. The number of product inspection labs totaled 27,051, of which 597 were national centers. […]
The Australian government has published a “National Innovation & Science Agenda,” to which AUD 1.1 billion ($80.3 million) will be allocated over four years. The Agenda consists of four pillars: Culture and Capital, Collaboration, Talent and Skills, and Government as an Exemplar. The pillar of Culture and Capital addresses funding shortfalls for technology development, and […]
China, the second largest drug market, has increased its commitment to its domestic pharmaceutical industry. This year, sales of the country’s 10 largest pharmaceutical companies grew an average of 12%, according to IMS Consulting. Multinational drug firms, including Novo Nordisk and GlaxoSmithKline, report increased competition. Domestic firms, such as Gan & Lee Pharmaceuticals and Fosun […]
R&D spending by the top 25 Indian pharmaceutical companies rose 28.8% to INR 9,250 crore ($1.4 billion) for the year ending March 2015. Sales as a percentage of revenues rose from 6.6% to 7.0%. The top three R&D spenders were Sun Pharmaceutical Industries, whose expenditures rose 87.0% to INR 1,856 crore; Dr. Reddy’s Laboratories, whose […]
The latest UK spending review includes increased funding for science, providing an additional £500 million ($769 million) per year by 2020 for the £4.7 billion science budget in order to account for inflation. In addition, the science infrastructure budget will increase 10% to £1.2 billion per year by 2021 and includes £150 million for a […]
The EU has named a seven-person Scientific Advice Mechanism (SAM) that will assist the European Commission (EC) with science-related policies and decisions. The panel replaces the position of the chief scientific advisor, the last of whom resigned in 2014. Allocated €6 million ($6 million) and its own staff, the SAM is designed to be an […]
As a result of budget shortfalls, the Indian Ministry of Science and Technology is requiring the Council of Scientific and Industrial Research’s (CSIR) labs to raise half of their funds through external sources and grants. The labs must also send the Ministry monthly updates on the progress of their research, and specify the aspects of […]
Importing biomaterials, such as mice and plants, will become easier for Chinese companies and research institutes next year. Having been implemented on a trial basis for two years in Beijing and Shanghai, reforms of the current rules will increase the competitiveness of the country’s bioindustry and facilitate greater international collaboration with partners. Currently, China must […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
